// STATE LEGISLATION TRACKER

Ohio HB 556: Revise community control sanctions for felonies and misdemeanors

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: In committee

State: Ohio
Bill: HB 556
Session: 136
Filed: 2025-10-28
Read the bill: OpenStates →
Last reviewed: 2026-10-05

Plain-English Summary

Ohio HB556 appears to be a criminal sentencing bill about community control sanctions for felony and misdemeanor cases. Based on the title, subjects, and available status, it does not target compounded peptides, off-label prescribing, telehealth, clinician scope, FDA 503A/503B compounding, or prescription monitoring.

Key Points

No apparent change to peptide prescribing or patient access
No apparent change to 503A or 503B pharmacy compounding rules
No apparent change to telehealth prescribing or follow-up care
No apparent change to NP or naturopathic scope of practice
Controlled-substance impact appears limited to criminal sentencing context

What to Watch For

Note Watch for amendments that add drug-specific sentencing or monitoring language.

Note If peptide users are under court supervision, sanction rules could matter personally, not market-wide.

Note Committee changes could broaden the bill beyond community control sanctions.

Where the Bill Stands

The bill has been introduced and referred to the House Judiciary Committee, but has not passed a chamber.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws